Background It is common for patients with neurofibromatosis type 2 to develop bilateral
profound hearing loss hearing loss, and this is one of the main determinants of quality of life …

Abstract The Auditory Brainstem Implant (ABI) is based on the classic cochlear implant (CI)
but uses a different stimulation electrode. At MED-EL, the early development activities on …

BACKGROUND: Management of neurofibromatosis type 2 (NF2)—associated vestibular
schwannomas (VSs) remains controversial. Stereotactic radiosurgery (SRS) with …

OBJECTIVE The object of this study was to ascertain outcomes of cochlear implantation (CI)
following stereotactic radiosurgery (SRS) for vestibular schwannoma (VS). METHODS The …

Objective: To describe the experience of auditory brainstem implantation (ABI) in patients
with Neurofibromatosis type 2 (NF2). Study Design: Retrospective case review. Setting …

BACKGROUND: NF2-schwannomatosis (NF2) is an autosomal dominant disorder prone to
hearing loss. Auditory brainstem implants (ABIs) offer a promising solution for hearing …

In neurofibromatosis type 2 (NF2) bilateral vestibular schwannomas (VS) or their treatment
usually results in bilateral hearing loss. Cochlear implantation (CI) was traditionally not used …

Objective To elucidate the differences in auditory performance between auditory brainstem
implant (ABI) patients with tumor or nontumor etiologies. Data Sources PubMed, Embase …

Bilateral vestibular schwannomas are almost pathognomonic of neurofibromatosis type 2
(NF2). As a result of these tumors, hearing loss is the presenting symptom in 60% of adults …

Vestibular schwannoma (VS) is the most common tumor of the cerebellopontine angle
(CPA) with an incidence of approximately 1 in 100,000. 1 The most common presenting …